State Street’s VIVEVE MED INC VIVE Stock Holding History

State Street’s Portfolio VIVE Stock Details VIVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-55,369	Closed	-$23.3K	–	4913
2022 Q4	$23.3K	Hold	55,369	–	–	﹤0.01%	4706
2022 Q3	$38K	Hold	55,369	–	–	﹤0.01%	4716
2022 Q2	$36K	Hold	55,369	–	–	﹤0.01%	4795
2022 Q1	$59K	Buy	55,369 +661	+1%	+$662	﹤0.01%	4769
2021 Q4	$62K	Hold	54,708	–	–	﹤0.01%	4668
2021 Q3	$125K	Hold	54,708	–	–	﹤0.01%	4492
2021 Q2	$162K	Buy	+54,708	New	+$154K	﹤0.01%	4264
2019 Q3	–	Sell	-11	Closed	-$4K	–	3829
2019 Q2	$4K	Hold	11	–	–	﹤0.01%	3810
2019 Q1	$11K	Hold	11	–	–	﹤0.01%	3723
2018 Q4	$12K	Sell	11 -2	-15%	-$4.8K	﹤0.01%	3726
2018 Q3	$34K	Hold	13	–	–	﹤0.01%	3711
2018 Q2	$34K	Sell	13 -309	-96%	-$890K	﹤0.01%	3702
2018 Q1	$1.18M	Buy	322 +87	+37%	+$378K	﹤0.01%	3314
2017 Q4	$1.17M	Buy	235 +31	+15%	+$161K	﹤0.01%	3325
2017 Q3	$1.06M	Buy	204 +25	+14%	+$154K	﹤0.01%	3366
2017 Q2	$1.28M	Buy	+179	New	+$1.33M	﹤0.01%	3286

Other funds holding VIVE

Cantor Fitzgerald New York $9.31B AUM 73.66% 1-Year Est. Return

State Street's VIVE Position: Q1 2023 in Review

State Street sold out of VIVEVE MED INC (VIVE) in Q1 2023, closing a stake of 55,369 shares — an estimated $23.3K sold.

State Street first reported a position in VIVE in Q2 2017 and held it in 16 quarters. The position peaked at $1.28M in Q2 2017. 1 fund tracked by Wall St. Rank holds VIVE as of Q1 2023.

State Street reported no remaining VIVEVE MED INC position as of Q1 2023 after selling out during the quarter.
State Street sold 55,369 VIVEVE MED INC shares in Q1 2023, an estimated $23.3K.
State Street first reported a position in VIVEVE MED INC in Q2 2017 and held it in 16 quarters.
State Street's VIVEVE MED INC position peaked at $1.28M in Q2 2017.
1 fund tracked by Wall St. Rank held VIVEVE MED INC as of Q1 2023.

Based on State Street's 13F filing for Q1 2023, filed 15 May 2023.